Fortrea Holdings Inc. (FTRE) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Fortrea Holdings Inc. stock (FTRE) is currently trading at $9.44. Fortrea Holdings Inc. PS ratio (Price-to-Sales) is 0.33. Analyst consensus price target for FTRE is $14.35. WallStSmart rates FTRE as Sell.
- FTRE PE ratio analysis and historical PE chart
- FTRE PS ratio (Price-to-Sales) history and trend
- FTRE intrinsic value — DCF, Graham Number, EPV models
- FTRE stock price prediction 2025 2026 2027 2028 2029 2030
- FTRE fair value vs current price
- FTRE insider transactions and insider buying
- Is FTRE undervalued or overvalued?
- Fortrea Holdings Inc. financial analysis — revenue, earnings, cash flow
- FTRE Piotroski F-Score and Altman Z-Score
- FTRE analyst price target and Smart Rating
Fortrea Holdings Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Fortrea Holdings Inc. (FTRE) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.
Fortrea Holdings Inc. (FTRE) Key Strengths (4)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
103.89% of shares held by major funds and institutions
Trading at 1.58x book value, attractively priced
Supporting Valuation Data
Fortrea Holdings Inc. (FTRE) Areas to Watch (6)
Company is destroying shareholder value
Revenue declining -5.20%, a shrinking business
Earnings declining -57.40%, profits shrinking
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Small-cap company with higher risk but more growth potential
Fortrea Holdings Inc. (FTRE) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.5/10) while 6 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.34), Price/Sales (0.33), Price/Book (1.58) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, EPS Growth. Growth concerns include Revenue Growth at -5.20%, EPS Growth at -57.40%, which may limit upside. Profitability pressure is visible in Return on Equity at -102.40%, Operating Margin at 1.33%, Profit Margin at -36.20%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -102.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -5.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
FTRE Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
FTRE's Price-to-Sales ratio of 0.33x trades 47% below its historical average of 0.62x (18th percentile). The current valuation is 75% below its historical high of 1.3x set in Mar 2024, and 118% above its historical low of 0.15x in May 2025. Over the past 12 months, the PS ratio has expanded from ~0.3x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Fortrea Holdings Inc. (FTRE) · HEALTHCARE › BIOTECHNOLOGY
The Big Picture
Fortrea Holdings Inc. is in a turnaround phase, with management focused on restoring profitability. Revenue reached 2.7B with 5% decline year-over-year. The company is currently unprofitable, posting a -36.2% profit margin.
Key Findings
Generating 122M in free cash flow and 129M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 5% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -36.2% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 1.78, so expect amplified moves relative to the broader market.
Debt management: total debt of 1.2B is significantly higher than cash (131M). Monitor refinancing risk.
Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact Fortrea Holdings Inc..
Bottom Line
Fortrea Holdings Inc. is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Fortrea Holdings Inc.(FTRE)
NASDAQ
HEALTHCARE
BIOTECHNOLOGY
USA
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.